YOLFTbeta
Xizang Haisco Pharmaceutical Group Co Ltd

Xizang Haisco Pharmaceutical Group Co Ltd

002653 · SHE · Healthcare / Biotechnology

58.03CNY-0.83 (-1.41%)

Price History

Full chart

Market Stats

Previous Close58.86
Open58.92
Day Range57.83 – 59.01
52-Week Range41.84 – 80.20
Volume3.08M
Market Cap70.94B
P/E (TTM)73.15
Forward P/E0.00
EPS0.85
Dividend Yield1.28%
Beta-0.21
50-Day Avg65.97
200-Day Avg56.95

About

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Pangke Yan
  • Employees5.60K
  • HeadquartersNo. 17 Sanxiang Avenue, Shannan, China, 856000, China
  • Websitehttps://www.haisco.com

Leadership

  • Mr. Pangke YanGM & Director · b. 1980
  • Ms. Peng DuanChief Financial Officer · b. 1977
  • Mr. Meng WangDeputy GM & Board Secretary · b. 1986
  • Da Guo TanAccounting Supervisor
  • Mr. Rui Bin WangDeputy General Manager · b. 1962

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue358.76M484.57M581.59M604.43M802.07M992.34M1.21B1.21B1.44B1.86B3.43B3.94B3.33B2.77B3.02B3.36B3.72B4.39B
Growth (%)-+35.07%+20.02%+3.93%+32.70%+23.72%+21.99%+0.15%+18.41%+29.29%+84.61%+14.90%-15.44%-16.71%+8.73%+11.27%+10.92%+17.91%
Cost of Revenue109.49M140.87M199.70M200.95M204.31M268.70M366.95M401.32M371.69M658.79M1.49B1.35B1.07B946.88M925.27M971.25M1.06B1.27B
Gross Profit249.27M343.70M381.89M403.48M597.76M723.64M843.65M811.13M1.06B1.20B1.93B2.59B2.26B1.83B2.09B2.38B2.66B3.12B
Gross Margin69.48%70.93%65.66%66.75%74.53%72.92%69.69%66.90%74.11%64.51%56.40%65.76%67.93%65.86%69.31%71.05%71.47%71.16%
Operating Expense40.39M74.34M91.20M122.63M276.80M262.34M389.13M406.05M732.09M931.41M1.61B2.04B1.56B1.31B1.73B2.07B2.15B2.80B
Operating Income208.89M269.36M290.69M280.85M320.96M461.30M454.52M405.08M331.82M265.96M323.96M546.80M698.80M512.26M364.44M313.53M507.45M323.84M
Operating Margin58.22%55.59%49.98%46.47%40.02%46.49%37.54%33.41%23.11%14.33%9.45%13.89%20.99%18.47%12.09%9.35%13.64%7.38%
EBITDA224.18M323.46M376.58M388.11M342.17M443.12M429.66M390.98M322.41M172.16M235.33M410.94M332.93M183.93M317.33M544.25M498.35M584.33M
EBITDA Margin62.49%66.75%64.75%64.21%42.66%44.65%35.49%32.25%22.46%9.28%6.87%10.44%10.00%6.63%10.52%16.22%13.39%13.32%
Net Income195.09M283.72M305.75M312.30M443.06M519.22M450.54M372.16M442.78M237.55M333.23M493.89M636.62M345.06M277.07M295.11M395.46M259.58M
Net Income Margin54.38%58.55%52.57%51.67%55.24%52.32%37.22%30.69%30.84%12.80%9.72%12.54%19.12%12.44%9.19%8.80%10.63%5.92%
R&D8.26M18.87M23.95M32.18M62.85M60.57M126.14M157.49M127.13M119.20M204.22M235.42M405.53M434.13M447.87M516.67M624.13M804.29M
R&D as % of Total Revenue2.30%3.89%4.12%5.32%7.84%6.10%10.42%12.99%8.86%6.42%5.96%5.98%12.18%15.65%14.85%15.40%16.77%18.33%
Interest Expense1.72M1.83M1.59M132.85K727.03K3.36M11.71M14.69M19.27M25.95M20.55M28.49M31.51M28.78M51.79M42.28M38.19M32.53M
Interest Expense % of Total Revenue0.48%0.38%0.27%0.02%0.09%0.34%0.97%1.21%1.34%1.40%0.60%0.72%0.95%1.04%1.72%1.26%1.03%0.74%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets353.69M349.39M629.88M882.70M1.95B2.46B2.87B3.23B3.74B4.11B4.37B5.04B5.00B5.01B6.05B6.65B6.80B7.01B
Total Liabilities138.73M214.22M176.79M114.95M238.49M530.24M767.55M1.07B1.50B2.14B2.37B2.66B2.15B2.09B2.91B2.48B2.60B2.72B
Total Equity214.95M135.17M453.09M767.76M1.71B1.93B2.11B2.16B2.25B1.99B2.03B2.37B2.90B2.84B3.04B4.18B4.21B4.29B
Cash76.52M120.72M375.54M498.42M1.29B1.05B858.05M1.19B1.18B1.02B617.38M892.75M453.97M575.11M775.39M1.17B1.06B1.39B
Total Debt6.30M12.06M21.07M450.46K50.00M229.69M400.00M632.47M801.91M600.00M905.00M729.90M1.08B915.50M1.80B965.51M1.17B-
Net Debt-70.22M-108.66M-354.47M-497.97M-1.24B-824.83M-458.05M-561.73M-374.31M-422.42M287.62M-162.85M622.67M340.38M1.03B-203.20M115.67M-

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow94.45M368.21M367.38M260.79M464.75M568.41M502.57M443.03M409.20M391.81M472.61M764.26M206.21M35.80M94.55M449.58M442.05M786.00M
Investing Cash Flow-37.34M-41.07M-80.41M-117.64M-948.21M-577.28M-273.57M-209.39M13.37M-229.83M-244.93M-514.83M-559.19M281.97M-539.88M-383.19M-301.61M-
Financing Cash Flow-8.14M-282.93M-31.85M-19.92M544.95M-115.82M-109.33M-106.11M-136.88M-316.11M-446.60M28.90M-85.01M-187.23M624.23M328.07M-250.68M-
Capital Expenditure37.38M24.01M80.95M117.72M125.30M163.98M234.86M283.68M208.24M393.26M351.98M582.68M601.72M702.94M700.17M391.01M440.65M331.98M
Free Cash Flow57.07M344.21M286.43M143.07M339.45M404.43M267.71M159.35M217.87M-1.45M120.62M181.58M-395.51M-667.14M-605.62M58.57M1.39M454.03M
Dividends Paid1.71M281.83M122.22M954.03K240.79M303.43M270.07M230.51M286.49M510.39M325.89M203.23M130.75M426.21M247.49M42.57M422.04M333.15M
FCF to OCF60.42%93.48%77.97%54.86%73.04%71.15%53.27%35.97%53.24%-0.37%25.52%23.76%-191.80%-1863.45%-640.56%13.03%0.31%57.76%
Dividend Paid to FCF3.00%81.88%42.67%0.67%70.93%75.03%100.88%144.65%131.49%-35257.24%270.17%111.92%-33.06%-63.89%-40.87%72.69%30338.38%73.38%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 27, 2014Mar 1, 2015Apr 22, 2015Aug 19, 2015Oct 30, 2015Feb 26, 2016Apr 14, 2016Jul 25, 2016Oct 24, 2016Mar 1, 2017Apr 28, 2017Aug 15, 2017Oct 27, 2017Apr 12, 2018Aug 20, 2018Oct 25, 2018Feb 26, 2019Apr 23, 2019Aug 5, 2019Oct 27, 2019Feb 28, 2020Apr 28, 2020Aug 18, 2020Oct 29, 2020Feb 26, 2021Apr 27, 2021Aug 26, 2021Oct 29, 2021Apr 28, 2022Aug 16, 2022Oct 26, 2022Apr 24, 2023Aug 16, 2023Oct 30, 2023Dec 31, 2023Apr 19, 2024Aug 15, 2024Oct 29, 2024May 30, 2025Aug 25, 2025Oct 29, 2025Apr 28, 2026Aug 27, 2026
EPS Estimate----------0.260.23------0.090.12---0.120.12-0.01-0.160.120.10-------------0.050.050.060.08---0.500.26
EPS Actual0.080.100.100.140.070.140.120.150.080.140.120.090.090.110.060.090.040.180.070.130.040.090.070.130.080.150.030.050.170.140.200.120.090.170.220.270.03-0.040.020.040.030.150.040.110.090.090.070.190.040.070.150.500.26
Surprise-----------53.85%-60.87%-------22.22%8.33%---8.33%-33.33%-200.00%-6.25%16.67%100.00%-------------80.00%80.00%9.33%137.50%---0.02%0.00%
Timing----------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-----

Key Statistics & Ratios

Market Cap70.94B
Enterprise Value74.97B
Trailing P/E73.15
Forward P/E0.00
PEG Ratio0.00
Price / Sales12.94
Price / Book15.51
EPS0.85
Book Value4.26
Revenue (TTM)5.48B
Gross Profit (TTM)4.14B
EBITDA1.13B
Profit Margin17.32%
Operating Margin16.90%
Return on Equity21.39%
Return on Assets7.00%
Shares Outstanding1.14B
Shares Float266.08M
Beta-0.21
Dividend Yield1.28%
Dividend Rate0.79
Payout Ratio87.26%

Dividends

20262×
0.53Sep 4, 20260.27May 15, 2026
20252×
0.14May 15, 20250.14Jan 24, 2025
20242×
0.14Sep 18, 20240.20May 24, 2024
20221×
0.19Jul 5, 2022
20211×
0.37Apr 28, 2021
20201×
0.09Jul 3, 2020
20191×
0.19May 15, 2019
20181×
0.28Jul 2, 2018
20171×
0.46Jun 9, 2017
20161×
0.25Apr 26, 2016
20151×
0.20May 27, 2015
20141×
0.25May 19, 2014
20131×
0.28Mar 11, 2013
20121×
0.22Mar 8, 2012

Stock Splits

  • Sep 12, 20131.35:1
  • Mar 11, 201320:10